13 participants
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-03-23
- Start Date:
- 2007-10-31
- Completion:
- 2011-01-31
Conditions
- Mesothelioma
Interventions
- DRUG